Ravi is an Investment Director responsible for evaluating and executing transactions, as well as supporting the origination of investment opportunities. Ravi worked on our investments in MYCOM OSI , Auxadi, Phenna Group, Digital Wholesale Solutions, SteriPack & YER.
Prior to joining Inflexion in 2018, Ravi spent four years at Rothschild working within the Healthcare M&A team. He completed a number of high-profile transactions in both pharmaceuticals and healthcare services, including the sale of Oasis Dental Care to BUPA and the acquisition of Compeed by HRA Pharma.
Outside work, Ravi is a sports enthusiast and enjoys spending his free time watching and playing a variety of sports (particularly football and tennis). Ravi is also a keen traveller and likes to visit new places and discover new cuisines.
Ravi has a degree in Economics from Cambridge University.
